The study also showed that a panel consisting of miR-122-5p, miR-486-5p and miR-142-3p was capable of distinguishing HCC from cirrhosis while outperforming the only current biomarker alpha-fetoprotein (AFP). The gene discussed is AFP; the disease is Cirrhosis.